Drug use beyond the licence in palliative care: A systematic review and narrative synthesis

V Hagemann, C Bausewein, C Remi - Palliative medicine, 2019 - journals.sagepub.com
Background: Drug use beyond the licence (off-label use, off-label drug use) is a common
practice in palliative care and respective recommendations can often be identified in the …

Off-label-prescriptions in daily clinical practice–a cross-sectional national survey of palliative medicine physicians

V Hagemann, C Bausewein, C Rémi - Progress in Palliative Care, 2019 - Taylor & Francis
Background: Off-label-use is an indispensable element of palliative medicine. Up to one
third of all drugs are prescribed beyond their licence. It is challenging to find the right …

[PDF][PDF] Pozarejestracyjne zastosowanie leków w opiece paliatywnej w Polsce

T Dzierżanowski, T Grądalski, M Graczyk… - Palliative Medicine …, 2020 - researchgate.net
Wstęp: Pozarejestracyjne zastosowanie leku ma miejsce wówczas, gdy podawany jest on
we wskazaniach, dawkach, formach, drogami podania oraz w grupach pacjentów …

[PDF][PDF] Anwendungspraxis von Arzneimitteln außerhalb der Zulassung in deutschen Einrichtungen der spezialisierten palliativmedizinischen Versorgung

VC Hagemann - 2022 - edoc.ub.uni-muenchen.de
Off-label drug use is an essential part of medicine. The terms 'off-label or unlicenced
use'refer to the agreed terms of use as stated in the Marketing Authorization ('label'). Besides …

Off-label drug use in palliative care in Poland

T Dzierżanowski, T Grądalski, M Graczyk… - Medycyna Paliatywna … - termedia.pl
Aim Research in the population of palliative care patients, for ethical reasons, is significantly
limited, and even impossible, so drug use is often based on the clinician's experience …